Geron Corp. (GERN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.57+3.97%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GERN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | 0.2 | 0.6 | 1.4 | 0.3 | 0.5 | 1.1 | 1.1 | 6.2 | 36.4 | — | 1.3 | 2.7 | 2.4 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1.1 | 6.2 | 36.4 | — | 1.3 | 2.7 | 2.4 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 155.0 | 159.3 | 145.7 | 69.1 | 43.6 | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income | (51.8) | (68.6) | (173.7) | (193.9) | (138.6) | (114.0) | (76.9) | (72.5) | (31.1) | (29.3) | (30.6) | (0.6) | (36.3) | (39.0) | (71.8) | (96.1) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 32.7 | 18.5 | 8.3 | 6.9 | 3.7 | 0.8 | — | — | — | — | — | — | — | — | — |
| Interest & Investment Income | 14.7 | 18.1 | 19.6 | 18.2 | 2.5 | 0.5 | 1.8 | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | (9.8) | 4.4 | 3.2 | (1.1) | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (83.4) | (174.5) | (181.7) | (141.9) | — | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | 0.1 | 0.4 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (67.6) | (83.5) | (174.6) | (184.1) | (141.9) | (116.1) | (75.6) | (68.5) | (27.0) | (27.9) | (29.5) | 0.0 | (35.7) | (38.4) | (68.9) | (96.9) |
| Per Share | ||||||||||||||||
| Basic EPS | (100.81) | (0.13) | (0.27) | (0.32) | (0.37) | (0.35) | (0.28) | — | — | (0.18) | (0.19) | 0.00 | — | — | — | — |
| Diluted EPS | (100.81) | (0.13) | (0.27) | (0.32) | (0.37) | (0.35) | (0.28) | — | — | (0.18) | (0.19) | 0.00 | — | — | — | — |
| Basic Weighted Avg Shares | 0.7 | 666.7 | 646.0 | 570.6 | 380.8 | 327.6 | 271.5 | — | — | 159.2 | 159.0 | 158.0 | — | — | — | — |
| Diluted Weighted Avg Shares | 0.7 | 666.7 | 646.0 | 570.6 | 380.8 | 327.6 | 271.5 | — | — | 159.2 | 159.0 | 162.7 | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (68.1) | (173.2) | (193.5) | (138.3) | (113.8) | (76.8) | — | — | — | — | — | — | — | — | — |
| EBIT | (51.8) | (68.6) | (173.7) | (193.9) | (138.6) | (114.0) | (76.9) | (72.5) | (31.1) | (29.3) | (30.6) | (0.6) | (36.3) | (39.0) | (71.8) | (96.1) |
| Effective Tax Rate | — | — | — | -0.0% | — | — | — | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.